The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in ...

Public health and infectious disease experts said they were surprised and confused about the move, and questioned why the HHS did not offer any reasoning for its decision.

Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox™ platform-based photoimmunotherapy, today announced that it was selected by the U.S. Food and Drug ...

And there is no F.D.A. requirement for a fatty acid called docosahexaenoic acid, or DHA, which is important for brain ...

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.